FDA Inspection 989402 — AlloSource
The FDA completed an inspection of AlloSource on Oct 24, 2016 in Maryland Heights, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 24, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Maryland Heights, MO (United States)